News & Events
News releases
SPH news
Four new Gillings Innovation Labs address pressing public health needs News & Events
| Four new Gillings Innovation Labs address pressing public health needs |
| March 23, 2009 | |
|
The UNC Gillings School of Global Public Health has announced funding for four new Gillings Innovation Laboratories, on topics as diverse as water and the environment, drug safety, statistical genomics, and 21st century public health teaching. All of these research projects have potential to benefit people across North Carolina and around the world. The latest awards are among 31 proposals submitted last fall. Proposals were reviewed by more than 100 subject-matter experts from around the country. Final decisions were made by the School's senior leadership, including the dean, associate deans and department chairs. Funding is for up to two years.
The four new innovation laboratories address some of public health's greatest challenges. Treating hog waste for energy recovery while meeting environmental goals ![]() Dr. Michael Aitken The project will be conducted on a swine farm in Harnett County, N.C.
Developing new methods and open source software for genetic research Recent advances in the study of human genetic variation and its relationship with disease represent some of the most important findings in the history of medicine and public health. The development and application of appropriate statistical methods is key to these advances. ![]() Dr. Danyu Lin ![]() Dr. Fred Wright An important aspect of this work will be development of user-friendly open source software. This innovation laboratory will help researchers throughout the world better understand genetic risks and better interpret the biological complexity of genetic association. The project will rely on the renowned strength of the School's biostatistics department and also will collaborate with other public health and medical experts. Determining benefit and harms drugs pose for older adults Clinical trials that measure the efficacy of medicines before they are approved for wider use usually do not provide sufficient evidence on the benefit to harm ratio that will be found when the new medicine is used on a broader scale in the general population. In particular, clinical trials rarely expose older patients or those taking other medications, often for different conditions in the same person. In addition, there never will be enough resources to conduct all the clinical trials that would be needed to answer important questions. ![]() Dr. Til Stürmer Anticipated benefits include safer and more effective treatments for people around the world. Global seamless classroom Technological advances have made it possible for students to share a class without sharing the room in which it is held. ![]() Dr. William Zelman Zelman and his team will seek to harness existing and emerging technologies and build on the experience and research in distance education that exists across the School and beyond. A major goal is to identify and begin integrating the approaches and opportunities presented by global, distance and classroom-based teaching. For more information on the Gillings Innovation Labs, please see www.sph.unc.edu/accelerate. # # # UNC Gillings School of Global Public Health contact: Ramona DuBose, director of communications, (919) 966-7467 or ramona_dubose@unc.edu. |
|
| Last updated March 22, 2009 |







